Synopsys, Inc. $SNPS Shares Sold by Schaper Benz & Wise Investment Counsel Inc. WI

Schaper Benz & Wise Investment Counsel Inc. WI lessened its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 21.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,971 shares of the semiconductor company’s stock after selling 1,616 shares during the quarter. Schaper Benz & Wise Investment Counsel Inc. WI’s holdings in Synopsys were worth $2,805,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the stock. Alpine Bank Wealth Management grew its stake in shares of Synopsys by 89.3% in the third quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock valued at $26,000 after buying an additional 25 shares in the last quarter. TFC Financial Management Inc. boosted its holdings in Synopsys by 1,250.0% during the 3rd quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock valued at $27,000 after acquiring an additional 50 shares during the period. Millstone Evans Group LLC purchased a new position in Synopsys during the 3rd quarter valued at about $27,000. SOA Wealth Advisors LLC. acquired a new position in Synopsys in the 3rd quarter valued at about $28,000. Finally, McIlrath & Eck LLC acquired a new position in Synopsys in the 3rd quarter valued at about $29,000. 85.47% of the stock is currently owned by institutional investors and hedge funds.

Synopsys Stock Down 3.9%

Shares of NASDAQ:SNPS opened at $415.62 on Wednesday. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73. The firm’s 50 day moving average price is $449.38 and its 200 day moving average price is $454.06. The company has a quick ratio of 1.26, a current ratio of 1.36 and a debt-to-equity ratio of 0.33. The stock has a market cap of $79.62 billion, a price-to-earnings ratio of 64.54, a price-to-earnings-growth ratio of 3.52 and a beta of 1.15.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, topping the consensus estimate of $3.56 by $0.21. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. The company had revenue of $2.41 billion during the quarter, compared to analysts’ expectations of $2.39 billion. During the same quarter in the previous year, the business posted $3.03 EPS. The firm’s revenue was up 65.6% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. As a group, equities research analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider Janet Lee sold 250 shares of the stock in a transaction on Monday, January 12th. The stock was sold at an average price of $530.00, for a total value of $132,500.00. Following the transaction, the insider owned 11,959 shares of the company’s stock, valued at $6,338,270. This represents a 2.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 0.56% of the stock is owned by company insiders.

Analyst Ratings Changes

Several analysts have recently issued reports on the stock. HSBC cut shares of Synopsys from a “buy” rating to a “hold” rating and set a $455.00 price target on the stock. in a research report on Friday, February 20th. Wall Street Zen raised shares of Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Rosenblatt Securities reduced their target price on shares of Synopsys from $560.00 to $530.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Needham & Company LLC reissued a “buy” rating on shares of Synopsys in a research report on Thursday, February 26th. Finally, Morgan Stanley restated an “equal weight” rating and issued a $480.00 price target (down from $550.00) on shares of Synopsys in a research note on Wednesday, February 25th. Eight analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $531.00.

Key Stories Impacting Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Activist investor Elliott has built a multibillion-dollar stake in Synopsys, which sparked an earlier rally by signaling potential pushes to improve software & services monetization and margins. This is a near-term catalyst for strategic or capital-allocation changes. CNBC Elliott Stake
• Positive Sentiment: Partnership with Arm to support the new Arm AGI data‑center CPU: Synopsys will supply EDA tools, interface IP and hardware‑assisted verification — reinforcing corporate exposure to AI/data‑center secular demand. PR Newswire Arm Partnership
• Positive Sentiment: Fundamentals remain solid: Synopsys beat Q1 earnings and revenue estimates in Feb., reported large year‑over‑year revenue growth, and issued FY2026 and Q2 EPS guidance — supporting the company’s long‑term AI/EDA growth story.
• Neutral Sentiment: Short‑interest data in recent feeds is inconsistent (reports show 0 shares / NaN changes), so short activity does not explain intraday pressure; treat those numbers with caution.
• Neutral Sentiment: Analyst landscape is mixed: several buy ratings and a median 12‑month target around $545, but some divergences exist — keeps consensus expectations in flux.
• Negative Sentiment: Profit‑taking and technical/headline fatigue: after the Elliott-driven pop, shares are pulling back — the stock sits below its 50‑ and 200‑day moving averages, which can accelerate selling by technical traders.
• Negative Sentiment: Insider selling and valuation concerns: recent disclosed insider sales and a high trailing P/E (~64x) may amplify short‑term caution among investors.
• Negative Sentiment: Competitive comparison: some analysts argue Nvidia’s (NVDA) superior data‑center momentum makes it a more attractive AI play right now, which can siphon relative investor interest away from Synopsys. Zacks NVDA vs SNPS

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.